Achilles Therapeutics plc reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 61.1 million compared to USD 33.2 million a year ago. Basic loss per share from continuing operations was USD 2.13 compared to USD 31.14 a year ago.